9
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Supportive Care - Essential for Modern Oncology

      Submit here before December 31, 2024

      About Oncology Research and Treatment: 2.0 Impact Factor I 3.2 CiteScore I 0.521 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      Increased Expression of Intercellular Adhesion Molecule 1, CD11/CD18 Cell Surface Adhesion Glycoproteins and α4β1 Integrin in a Rat Model of Chronic Interstitial Lung Fibrosis

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The expression of the intercellular adhesion molecule 1 (ICAM-1), and the integrins CD49, CD1 Vole, and CD1 la (LFA-1α chain) was analyzed in an experimental model of pulmonary fibrosis. Adult rats were exposed to 75% oxygen during 10 weeks, and to 2.0 mg/kg of paraquat twice weekly. Rats were sacrificed at 2 days, and at 2 and 10 weeks after the first injection of paraquat. Lungs were fixed in 4% paraformaldehyde and used for histology and immunohistochemistry. At 2 days the lungs showed a diffuse inflammation composed of a mixed polymorphonuclear and mononuclear cell infiltrate. Afterwards, the inflammatory process was predominantly mononuclear, and an increasing fibroblast proliferation was observed. Early inflammatory events (48 h) correlated with a moderate increased expression of ICAM-1, LFA, and CD1 lb/c in epithelial cells as well as a pronounced expression of ICAM-1 and CD1 lb/c in macrophages. At 2 and 10 weeks, there was a progressive increased expression of CD1 lb/c and ICAM-1 by macrophages, as well as of LFA in epithelial cells, and of ICAM-1 and CD49 by epithelial and interstitial cells. Lymphocytes showed a slight increased expression of LFA at 2 weeks, and of CD49 at 2 and 10 weeks. These results suggest that macrophages expressing ICAM-1, CD1 lb/c, and CD49 are involved in the earlier and late phases of the disease whereas fibroblast and epithelial cells expressing ICAM-1 and CD49 might play a role in the cell interactions involved in the fibrotic phase.

          Related collections

          Author and article information

          Journal
          PAT
          Pathobiology
          10.1159/issn.1015-2008
          Pathobiology
          S. Karger AG
          1015-2008
          1423-0291
          1996
          1996
          08 October 2008
          : 64
          : 4
          : 187-192
          Affiliations
          Department of Pathology, Children’s Memorial Hospital, Chicago, Ill., USA; Instituto Nacional de Enfermedades Respiratorias, and Facultad de Ciencias, Universidad Nacional Autónoma de Mexico, Mexico
          Article
          164034 Pathobiology 1996;64:187–192
          10.1159/000164034
          9031327
          5aaf746e-5890-4a42-9b48-e736fd858276
          © 1996 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 02 June 1996
          : 27 June 1996
          Page count
          Pages: 6
          Categories
          Original Paper

          Oncology & Radiotherapy,Pathology,Surgery,Obstetrics & Gynecology,Pharmacology & Pharmaceutical medicine,Hematology
          Lung fibrosis,Integrins,Fibrosis,Adhesion molecules,ICAM-1

          Comments

          Comment on this article